Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Di Blasi R, Le Gouill S, Bachy E, Cartron G, Beauvais D, Le Bras F, Gros FX, Choquet S, Bories P, Feugier P, Casasnovas O, Bay JO, Mohty M, Joris M, Gastinne T, Sesques P, Tudesq JJ, Vercellino L, Morschhauser F, Gat E, Broussais F, Houot R, Thieblemont C.
Di Blasi R, et al. Among authors: casasnovas o.
Blood. 2022 Dec 15;140(24):2584-2593. doi: 10.1182/blood.2022016945.
Blood. 2022.
PMID: 36122385
Free article.